Cardioprotective effect of sasanquasaponin preconditioning via bradykinin-NO pathway in isolated rat heart

Phytotherapy Research

Volumn 23, Issue 8, 2009, Pages 1146-1153

  Liao, Zhangping ^a   Yin, Dong ^a   Wang, Wufeng ^a   Zeng, Guohua ^a   Liu, Dan ^a   Chen, Heping ^a   Huang, Qiren ^a   He, Ming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Bradykinin; Ischemia reperfusion; Isolated rat heart; Nitric oxide; Preconditioning; Sasanquasaponin

Indexed keywords

BRADYKININ; GLUTATHIONE PEROXIDASE; ICATIBANT; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SAPONIN DERIVATIVE; SASANQUASAPONIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMIC PARAMETERS; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIAS, CARDIAC; BRADYKININ; CAMELLIA; CARDIOTONIC AGENTS; FEMALE; HEMODYNAMICS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPID PEROXIDATION; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SAPONINS;

CAMELLIA OLEIFERA; RATTUS;

EID: 68049113249     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2767     Document Type: Article

References (47)

1. Abete P, Napoli C, Santoro G, Ferrara N, Tritto I, Chiariello M, Rengo F, Ambrosio G. 1999. Age-related decrease in cardiac tolerance to oxidative stress. J Mol Cell Cardiol 31: 227-236. (Pubitemid 29078233)
2. Attle AS, Wu JA, Yuan CS. 1999. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
3. Baxter GF, Ebrahim Z. 2002. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 135: 843-854. (Pubitemid 34214443)
4. Bolli R. 1991. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 5: 249-268.
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Chen HP, He M, Huang QR, Liu D, Huang M. 2007. Sasanquasaponin protects rat cardiomyocytes against oxidative stress induced by anoxia-reoxygenation injury. Eur J Pharmacol 575: 21-27. (Pubitemid 47592908)
7. Cumming DV, Heads RJ, Coffin RS, Yellon DM, Latchman DS. 1996. Pharmacological preconditioning of primary rat cardiac myocytes by FK506. Basic Res Cardiol 91: 367-373.
8. Dhalla NS, Elmoselhi AB, Hata T, Makino N. 2000. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47: 446-456. (Pubitemid 30646067)
9. + channels. Basic Res Cardiol 99: 299-308.
10. Ebrahim Z, Yellon DM, Baxter GF. 2000. Bradykinin-induced cardioprotection is attenuated in the hypertrophied rat heart. Br J Pharmacol 129: 191P (abstract).
11. Ebrahim Z, Yellon DM, Baxter GF. 2001a. Omapatrilat lowers the threshold for induction of ischaemic preconditioning via activation of the bradykinin B2 receptor. Br J Pharmacol 133: 10P (abstract).
12. Ebrahim Z, Yellon DM, Baxter GF. 2001b. Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism. Am J Physiol Heart Circ Physiol. 281: H1458-H1464.
13. Feng JF, Li H, Rosenkranz ER. 2000. Bradykinin protects the rabbit heart after cardioplegic ischaemia via NO-dependent pathways. Ann Thorac Surg 70: 2119-2124. (Pubitemid 32015319)
14. Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera CM, Albertini A, Visioli O. 1985. Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol 17: 937-945. (Pubitemid 16228235)
15. Ferrari R, Ceconi C, Curello S, Cargnoni A, Pasini E, Visioli O. 1991. The occurrence of oxidative stress during reperfusion in experimental animals and men. Cardiovasc Drugs Ther 5: 277-287.
16. Flohe L, Gunzler WA. 1984. Assays of glutathione peroxidase. Methods Enzymol 105: 114-119.
17. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. 1995. Role of bradykinin in protection of ischaemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
18. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids. Anal Biochem 126: 131-138. (Pubitemid 13203451)
19. Hemnani T, Parihar MS. 1998. Reactive oxygen species and oxidative DNA damage. Indian J Physiol Pharmacol 42: 440-452. (Pubitemid 28557746)
20. Huang Q, He M, Chen HP, Shao L, Liu D, Luo Y, Dai Y. 2007. Protective effects of sasanquasaponin on injury of endothelial cells induced by anoxia and reoxygenation in vitro. Basic Clin Pharmacol Toxicol 101: 301-308. (Pubitemid 47512381)
21. Huang QR, Shao LJ, He M, Chen H, Liu D, Luo Y, Dai Y. 2005. Inhibitory effects of sasanquasaponin on over-expression of ICAM-1 and on enhancement of capillary permeability induced by burns in rats. Burns 31: 637-642. (Pubitemid 40905223)
22. Jeroudi MO, Hartley CJ, Bolli R. 1994. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 73: 2B-7B. (Pubitemid 24093495)
23. Krieg T, Qin Q, Philipp S, Alexeyev MF, Cohen MV, Downey JM. 2004. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol Heart Circ Physiol 287: H2606-H2611. (Pubitemid 39557130)
24. Kukreja RC. 1999. Role of KATP channel in heat shock and pharmacological preconditioning. Ann N Y Acad Sci 874: 211-221.
25. Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R. 1999. Bradykinin-induced preconditioning in patients under-going coronary angioplasty. J Am Coll Cardiol 34: 639-650. (Pubitemid 29436166)
26. Liu CX, Xiao PG. 1992. Recent advances on ginseng research in China. J Ethnopharmacol 36: 27-38.
27. Liu JC, Kang J, Shao LJ, He M. 2006. Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts. Zhonghua Yi Xue Za Zhi 86: 987-991 (Pubitemid 43950839)
28. Maxwell SR, Lip GY. 1997. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58: 95-117.
29. Miki T, Miura T, Ura N, Ogawa T, Suzuki K, Shimamoto K, Iimura O. 1996. Captopril potentiates the myocardial infarct size-limiting effect of ischaemic preconditioning through bradykinin B2 receptor activation. J Am Coll Cardiol 28: 1616-1622. (Pubitemid 26391871)
30. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. 2005. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100: 179-190. (Pubitemid 40502196)
31. Morris SD, Yellon DM. 1997. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradyki-nin B2 receptor activation in human heart. J Am Coll Cardiol 29: 1599-1606.
32. Nag AC, Cheng M. 1981. Adult mammalian cardiac muscle cells in culture. Tissue Cell 13: 515-523. (Pubitemid 12238453)
33. Napoli C, Cicala C, Wallace JL, de Nigris F, Santagada V, Caliendo G, Franconi F, Ignarro LJ, Cirino G. 2000. Protease-activated receptor-2 modulates myocardial ischemia reperfusion injury in the rat heart. Proc Natl Acad Sci USA 97: 3678-3683. (Pubitemid 30183362)
34. Niehaus WG Jr, Samuelsson B. 1968. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6: 126-130.
35. Park JL, Lucchesi BR. 1999. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 68: 1905-1912.
36. Peng WJ, Yu J, Deng S, Jiang JL, Deng HW, Li YJ. 2004. Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts. Can J Physiol Pharmacol 82: 339-344. (Pubitemid 39093700)
37. Schoelkens BA, Linz W. 1992. Bradykinin-mediated metabolic effects in isolated perfused rat hearts. Agents Actions Suppl 38: 36-42.
38. Schulz R, Post H, Vahlhaus C, Heusch G. 1998. Ischemic preconditioning in pigs: a graded phenomenon. Its relation to adenosine and bradykinin. Circulation 98: 1022-1029.
39. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, Wen J, Kubota T, Utsumi H, Takeshita A. 2004. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109: 544-549. (Pubitemid 38168520)
40. Sies H, Murphy ME. 1991. Role of tocopherols in the protection of biological systems against oxidative damage. J Photochem Photobiol B 8: 211-218.
41. Slater TF. 1984. Overview of methods used for detecting lipid peroxidation. Methods Enzymol 105: 283-293.
42. Spitz DR, Oberley LW. 1989. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 179: 8-18.
43. Toufektsian MC, Boucher FR, Tanguy S, Morel S, de Leiris JG. 2001. Cardiac toxicity of singlet oxygen: implication in reperfusion injury. Antioxid Redox Signal 3: 63-69. (Pubitemid 32240629)
44. Vanden Hoek TL, Shao Z, Li C, Zak R, Schumacker PT, Becker LB. 1996. Reperfusion injury on cardiac myocytes after simulated ischemia. Am J Physiol 270: H1334-H1341. (Pubitemid 26135963)
45. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW. 1988. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia infarction, and reperfusion. Cardiovasc Res 22: 447-455.
46. Wei M, Wang X, Kuukasjärvi P, Laurikka J, Rinne T, Honkonen EL, Tarkka M. 2004. Bradykinin preconditioning in coronary artery bypass grafting. Ann Thorac Surg. 78: 492-497. (Pubitemid 38980760)
47. Zhu P, Zaugg CE, Simper D, Hornstein P, Allegrini PR, Buser PT. 1995. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide and prostacyclin. Card Res 29: 658-663.